Security key
H0036K147
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Shares, par value CHF 0.08 per share
- Total 13F shares
- 28,226,306
- Total 13F value
- $921,776,783
- Share change
- +6,668,683
- SEC-reported price per share
- $32.99
- Number of holders
- 51
- Value change
- +$216,837,760
- Number of buys
- 37
- Number of sells
- 12
- Shares outstanding
- 128,459,465
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
51
Top holders
10
ADCT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2020
Previous quarter: Q2 2020
ADC Therapeutics SA SEC filings
ADC Therapeutics SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP H0036K147
Recent filing periods:
Ownership snapshot
Top reported holders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 4.3%
Showing 1-6 of 15 holder rows.
Quick read
Redmile Group, LLC leads the comparable SEC ownership view at 4.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Redmile Group, LLC's linked filing trail.
Comparable ownership
Top 5
Redmile Group, LLC
4.3%
FMR LLC
4.1%
BAKER BROS. ADVISORS LP
1.3%
Magnetar Financial LLC
1.2%
Grosvenor Holdings, L.L.C.
0.99%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
Company
|
4.3%
|
$258,666,000
5,525,870 shares
|
— | 30 Jun 2020 |
| FMR LLC |
13F
Company
|
4.1%
|
$245,483,000
5,244,231 shares
|
— | 30 Jun 2020 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
1.3%
|
$78,992,000
1,687,500 shares
|
— | 30 Jun 2020 |
| Magnetar Financial LLC |
13F
Company
|
1.2%
|
$64,414,000
1,563,438 shares
|
— | 30 Jun 2020 |
| Grosvenor Holdings, L.L.C. |
13F
Company
|
0.99%
|
$59,786,000
1,277,212 shares
|
— | 30 Jun 2020 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.89%
|
$53,493,000
1,142,773 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
28,226,306
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
41
Q3 2020 holders
51
Holder diff
10
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend